Pyramid Biosciences Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50M
Pyramid Biosciences General Information
Description
Operator of an oncology company intended to treat disorders that the tropomyosin receptor kinase family regulates. The company's therapeutics include precisely and selectively modulating the actions of fundamental cell surface receptors and controlling the key signaling pathways responsible for a patient's disease, condition, or symptoms, enabling physicians to regulate the symptoms and alter the progression of diseases.
Contact Information
Website
www.pyramidbio.comCorporate Office
- 330 Bear Hill Road
- Suite 302
- Waltham, MA 02451
- United States
Corporate Office
- 330 Bear Hill Road
- Suite 302
- Waltham, MA 02451
- United States
Pyramid Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Jan-2024 | $50M | Completed | Clinical Trials - Phase 1 | ||
| 6. Later Stage VC (Series B) | 15-Oct-2021 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series A3) | 31-Aug-2020 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC (Series A2) | 28-Jul-2020 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC (Series A) | 28-Jul-2020 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 31-Jul-2018 | $17.3K | $17.3K | Completed | Clinical Trials - Phase 1 | |
| 1. Angel (individual) | 01-Jan-2016 | Completed | Clinical Trials - Phase 1 |
Pyramid Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | 1,500,000 | $0.000100 | 8% | $4 | $4 | 1x | $4 | 11.59% |
| Series A | 1,054,586 | $0.000100 | 8% | $3.44 | $3.44 | 1x | $3.44 | 8.15% |
Pyramid Biosciences Comparisons
Industry
Financing
Details
Pyramid Biosciences Competitors (78)
One of Pyramid Biosciences’s 78 competitors is Accent Therapeutics, a Venture Capital-Backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Accent Therapeutics | Venture Capital-Backed | Lexington, MA | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA | ||||
| Linnaeus Therapeutics | Venture Capital-Backed | Haddonfield, NJ | ||||
| Complix | Venture Capital-Backed | Diepenbeek, Belgium | ||||
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA |
Pyramid Biosciences Patents
Pyramid Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023248151-A1 | Method of treating skin field cancerization with actinic keratoses | Inactive | 24-Jun-2022 | ||
| AU-2021415273-A1 | Topical pharmaceutical compositions and methods | Inactive | 29-Dec-2020 | ||
| AU-2021415273-A9 | Topical pharmaceutical compositions and methods | Inactive | 29-Dec-2020 | ||
| CA-3204701-A1 | Topical pharmaceutical compositions and methods | Pending | 29-Dec-2020 | ||
| US-20240092778-A1 | Topical pharmaceutical compositions and methods | Pending | 29-Dec-2020 | C07D471/04 |
Pyramid Biosciences Signals
Pyramid Biosciences Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adage Capital Management | Hedge Fund | Minority | ||
| Alpine Meridian | Venture Capital | Minority | ||
| Boston Harbor Angels | Angel Group | Minority | ||
| Montanova Capital | Hedge Fund | Minority | ||
| Oracle Investment Management | Hedge Fund | Minority |
Pyramid Biosciences FAQs
-
When was Pyramid Biosciences founded?
Pyramid Biosciences was founded in 2015.
-
Where is Pyramid Biosciences headquartered?
Pyramid Biosciences is headquartered in Waltham, MA.
-
What is the size of Pyramid Biosciences?
Pyramid Biosciences has 11 total employees.
-
What industry is Pyramid Biosciences in?
Pyramid Biosciences’s primary industry is Drug Discovery.
-
Is Pyramid Biosciences a private or public company?
Pyramid Biosciences is a Private company.
-
What is the current valuation of Pyramid Biosciences?
The current valuation of Pyramid Biosciences is .
-
What is Pyramid Biosciences’s current revenue?
The current revenue for Pyramid Biosciences is .
-
How much funding has Pyramid Biosciences raised over time?
Pyramid Biosciences has raised $71.2M.
-
Who are Pyramid Biosciences’s investors?
Adage Capital Management, Alpine Meridian, Boston Harbor Angels, Montanova Capital, and Oracle Investment Management are 5 of 6 investors who have invested in Pyramid Biosciences.
-
Who are Pyramid Biosciences’s competitors?
Accent Therapeutics, AsherBio, Linnaeus Therapeutics, Complix, and Actym Therapeutics are some of the 78 competitors of Pyramid Biosciences.
-
When was Pyramid Biosciences acquired?
Pyramid Biosciences was acquired on 07-Jan-2024.
-
Who acquired Pyramid Biosciences?
Pyramid Biosciences was acquired by Biohaven.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process